Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Price:
34.71
USD
-2.42%
Market Closed
Market Cap:
$3.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
R
|
Rayong Wire Industries PCL
SET:RWI
|
TH |
|
FTGroup Co Ltd
TSE:2763
|
JP |
|
Neway CNC Equipment Suzhou Co Ltd
SSE:688697
|
CN |
|
B
|
Biovaxys Technology Corp
OTC:BVAXF
|
CA |
|
Greiffenberger AG
F:GRF
|
DE |
|
Paragon Technologies Co Ltd
TWSE:3518
|
TW |
|
MDU Resources Group Inc
NYSE:MDU
|
US |
|
C
|
CyberAgent Inc
OTC:CYAGF
|
JP |
|
Jinhui Liquor Co Ltd
SSE:603919
|
CN |
|
B
|
Banpu PCL
SET:BANPU
|
TH |
|
Wondershare Technology Group Co Ltd
SZSE:300624
|
CN |
|
N
|
Nordnet AB (publ)
STO:SAVE
|
SE |
|
Avid Bioservices Inc
NASDAQ:CDMO
|
US |
|
Silitech Technology Corp
TWSE:3311
|
TW |
|
3
|
3Dm Digital Manufacturing Ltd
TASE:DM3
|
IL |
|
N
|
Nam Viet Corp
VN:ANV
|
VN |
|
Stark Technology Inc
TWSE:2480
|
TW |
|
O
|
Oriental Times Media Corp
SZSE:002175
|
CN |
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
IN |
|
T
|
Thai Rubber Latex Group PCL
SET:TRUBB
|
TH |
|
N2N Technologies Ltd
BSE:512279
|
IN |
|
Brookfield Renewable Corp
NYSE:BEPC
|
US |
|
Rand Capital Corp
NASDAQ:RAND
|
US |
Relative Value
The Relative Value of one
CRNX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 34.71 USD,
Crinetics Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRNX Relative Value
HIDDEN
Multiples Across Competitors
CRNX Competitors Multiples
Crinetics Pharmaceuticals Inc Competitors
Crinetics Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
3.3B USD | 431.1 | -7.1 | -5.1 | -5.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 72.5 | 80.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
